AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10199756
Drug: GnRH analog
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH analog alone (nafarelin acetate; 200 microg, intranasally, twice daily)
Trial: 8849298
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole (Funazol)
Trial: 29884405
Drug: Subretinal transplantation
RxNorm normalized name: Washed Microbiota Transplantation
DrugBank: Washed Microbiota Transplantation (DB15745)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subretinal transplantation of up to 200,000 hESC-derived RPE cells with systemic immunosuppressive therapy for 13 weeks
Trial: 11372002
Drug: Bezafibrate 400
RxNorm normalized name: bezafibrate 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate 400 mg/day
Trial: 28407999
Drug: Spacing strategy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spacing strategy (TNF-blocker injection spacing)
Trial: 15571316
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg once daily for 14 days
Trial: 11510874
Drug: Heat-induced dehydration
RxNorm normalized name: Dehydrated Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heat-induced dehydration after coffee consumption (caffeine 4.9 mg/kg, 3-4 cups)
Trial: 30737932
Drug: Endodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endodontic treatment with good quality root filling and good quality crown restoration (GE + GR)
Trial: 23801357
Drug: Ponatinib 15
RxNorm normalized name: PONATinib 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponatinib 15 mg with ketoconazole 400 mg daily for 5 days
Trial: 28052451
Drug: Nadroparin infusion
RxNorm normalized name: nadroparin
DrugBank: Nadroparin (DB08813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin infusion (loading dose of 35 IU/kg and continuous infusion of 10 IU/kg per hour for 6 hours)
Trial: 371903
Drug: Calcium carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium carbimide (CC) 0.7 mg/kg
Trial: 31187863
Drug: DHA +
RxNorm normalized name: PNV-DHA + Docusate Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA + AA (200 mg each)
Trial: 6754416
Drug: Budesonide nasal
RxNorm normalized name: budesonide nasal
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide nasal spray (long-term use for more than two years)
Trial: 30942964
Drug: No-tablet control
RxNorm normalized name: caffeine Oral Tablet [No Doz]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-tablet control
Trial: 1667511
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose 250 ml
Trial: 22379116
Drug: Unacylated ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unacylated ghrelin (UAG) infusion (1.0 μg/kg per h)
Trial: 25864745
Drug: Food Supplement
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food Supplement (FS) alone
Trial: 25864745
Drug: Thyroid hormones
RxNorm normalized name: Thyroid hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormones alone
Trial: 15298427
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (30 mg/kg)
Trial: 16504873
Drug: 2-session treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-session treatment (calcium hydroxide as an intracanal dressing)
Trial: 3044007
Drug: Maprotiline 50
RxNorm normalized name: maprotiline 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline 50 mg
Trial: 2946975
Drug: Maprotiline 75
RxNorm normalized name: maprotiline 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline 75 mg
Trial: 1103916
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of diazepam 10 mg
Trial: 1103916
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration into the deltoid muscle of diazepam 10 mg
Trial: 20615781
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol (group A)
Trial: 8806288
Drug: SPf66 malaria
RxNorm normalized name: PLASMODIUM MALARIAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPf66 malaria vaccine
Trial: 30808670
Drug: Collagenase injection
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collagenase injection
Trial: 21899741
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g cinnamon
Trial: 11256241
Drug: Valaciclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 500 mg orally every 12 hours for 7 days
Trial: 31735178
Drug: Temporal fascia
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temporal fascia graft plus platelet-rich fibrin therapy
Trial: 8417172
Drug: Ribavirin 800
RxNorm normalized name: ribavirin 800 Dose Pack, 4 Unit Dose Packs, 14 Tablets Each
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin 800 mg daily
Trial: 8417172
Drug: Ribavirin 600
RxNorm normalized name: ribavirin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin 600 mg daily
Trial: 27599663
Drug: Subcutaneous tocilizumab
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous tocilizumab 162 mg every week
Trial: 27599663
Drug: Subcutaneous tocilizumab
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous tocilizumab 162 mg every 2 weeks
Trial: 27599663
Drug: Intravenous tocilizumab
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous tocilizumab 8 mg/kg every 4 weeks
Trial: 9202914
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of anaesthetic solution (0.5% bupivacaine with adrenaline 1:200,000 and 2% lignocaine)
Trial: 19223621
Drug: ST-246 administered
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ST-246 administered at 10 mg/kg/day for 14 days
Trial: 19223621
Drug: ST-246 administered
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ST-246 administered at 3 mg/kg to 100 mg/kg once a day for 14 days
Trial: 18928104
Drug: Rukang Tablet
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rukang Tablet (RKT)
Trial: 9679845
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate powder (50 microg or 100 microg twice daily)
Trial: 28051240
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of montelukast, azithromycin and bronchodilators or glucocorticoid
Trial: 27687537
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss + 2000IU oral vitamin D3/day
Trial: 17134770
Drug: Trimethazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethazidine (TMZ) 20 mg, tds
Trial: 28120446
Drug: Mirabegron 50
RxNorm normalized name: mirabegron 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron 50 mg
Trial: 28170104
Drug: Adapted mindfulness
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapted mindfulness intervention plus treatment as usual (n = 20)
Trial: 26329790
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg (day 3)
Trial: 27229470
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection and Lidocaine (IS)
Trial: 12810472
Drug: No therapeutic
RxNorm normalized name: Gel, Multi Ingredient Topical application Gel/Jelly [AVEENO THERAPEUTIC SHAVE GEL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapeutic treatment
Trial: 31223099
Drug: Slow infusion
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow infusion (10 h) of Zn (100 μmol)
Trial: 31223099
Drug: Fast infusion
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast infusion (1 h) of Mn (1000 nmol)
Trial: 15313860
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone sodium phosphate (1 mg/kg)
Trial: 7051913
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of elemental zinc as zinc acetate (10 patients)
Trial: 22893628
Drug: Denosumab 120
RxNorm normalized name: DENOSUMAB 120 MG/1.7 ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 120 mg subcutaneously every 4 weeks
Trial: 18077134
Drug: 0 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/d of supplemental Zn (placebo)
Trial: 2112080
Drug: Hungarian-made levonorgestrel
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hungarian-made levonorgestrel tablets (0.75 mg)
Trial: 20210680
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1000 mg twice daily
Trial: 20210680
Drug: Enteric-coated mycophenolate
RxNorm normalized name: mycophenolic acid
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated mycophenolate sodium (EC-MPS) 720 mg twice daily
Trial: 20357371
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 2.0 units/kg
Trial: 20357371
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 0.5 units/kg
Trial: 31304600
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose regimen (1500 IU anti-D at 28 weeks)
Trial: 18804142
Drug: Formulation F1
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation F1 (vehicle)
Trial: 18804142
Drug: Formulation F4
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation F4 (combination of vitamins and SCE)
Trial: 375121
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg apomorphine s.c. for 15 days
Trial: 24360050
Drug: No sedative
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No sedative anesthetic
Trial: 19783713
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil 1000 mg with pantoprazole 40 mg twice daily
Trial: 25569654
Drug: Fentanyl combined
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl combined with etomidate (fentanyl 1 to 2 μg/kg, etomidate 0.1 to 0.3 mg/kg)
Trial: 29751193
Drug: Low added
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low added sugar adequate fiber diet (LASAF; 5% total energy from AS and 13.5 g fiber/1000 kcal)
Trial: 17029618
Drug: RF-NaP 32
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RF-NaP 32 tablets (48 g)
Trial: 9425505
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist and calcium, with or without nasal salmon calcitonin
Trial: 4604478
Drug: Ogawa vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ogawa vaccine
Trial: 30635477
Drug: Rituximab induction
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab induction followed by glatiramer acetate (GA) monotherapy
Trial: 9301631
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin twice a day
Trial: 23127169
Drug: Photosensitizer group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photosensitizer group (tolouidine blue O, 0.1 mg/ml)
Trial: 20526200
Drug: Dynamic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic treatment regimen (take hormone therapy until certain adverse events become apparent, then stop)
Trial: 17318527
Drug: Enteral nimodipine
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteral nimodipine (60 mg tablet/suspension at 4-h intervals)
Trial: 17318527
Drug: Intravenous nimodipine
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nimodipine (2 mg/h continuous infusion)
Trial: 15241347
Drug: Pranlukast 300
RxNorm normalized name: pranlukast
DrugBank: Pranlukast (DB01411)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Pranlukast 300 mg twice daily
Trial: 23754545
Drug: mesalazine 800
RxNorm normalized name: mesalazine 800 MG Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mesalazine 800 mg twice daily for 10 days every month
Trial: 12466334
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of long-term GH treatment
Trial: 10769103
Drug: Nerve root
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve root injection of 0.10 g of lidocaine hydrochloride and 3.75 mg of cortivazol
Trial: 10421236
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of [1‐13C]alanine for 3.5 hours
Trial: 10421236
Drug: Nasogastric tube
RxNorm normalized name: nasogastric tube
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasogastric tube infusion of [1‐13C]alanine for 3.5 hours
Trial: 8751234
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg once daily for 7 days
Trial: 14503053
Drug: WM group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WM group (chemotherapy)
Trial: 21677054
Drug: Protein-energy supplements
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-energy supplements (1015 kcal and 22 g protein/d) provided to pregnant women from 20 weeks gestation until delivery
Trial: 9383487
Drug: Fast injection
RxNorm normalized name: Fast Freeze
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fast injection of unbuffered lidocaine
Trial: 30273622
Drug: Topical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prostaglandin analog (latanoprost)
Trial: 12969089
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg o.d., tinidazole 500 mg b.d., rabeprazole 20 mg b.d. for 10 days (LTR)
Trial: 2903936
Drug: Benzodiazepine antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Benzodiazepine antagonist
Trial: 25886536
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution and standard care
Trial: 15480128
Drug: Fluoroscopically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopically guided bilateral facet injections plus supervised stretching exercises (Group A, n = 36)
Trial: 20498389
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg/d
Trial: 3141640
Drug: Lipid infusion
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid infusion
Trial: 9033441
Drug: Inhaled broxaterol
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled broxaterol 400 micrograms t.i.d.
Trial: 9931626
Drug: Neoadjuvant radio-
RxNorm normalized name: Valerianae radix
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant radio- and/or chemotherapy
Trial: 9280178
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil plus sunflower oil (average EPA + DHA intake: 5.2 g/d)
Trial: 8393884
Drug: Aspirin (oral)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (oral)
Trial: 27154871
Drug: Simulated pills
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated pills (Control)
Trial: 10845730
Drug: Levetiracetam 2000
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam 2000 mg daily
Trial: 23299064
Drug: Cefuroxime 250
RxNorm normalized name: cefuroxime 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 250 mg twice daily for 10 days (n=57)
Trial: 27348693
Drug: Structured exercise
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured exercise group (non-operative treatment)
Trial: 541683
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis B vaccine
Trial: 21482964
Drug: High-dose multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose multivitamin (folic acid, vitamin B6, and vitamin B12)
Trial: 12171372
Drug: Family intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Family intervention (single family therapy)
Trial: 30201821
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone treatment
Trial: 15121121
Drug: Dermagraft and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermagraft and compression therapy
Trial: 31575585
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injections (BOTOX) at 8 UI/kg in the internal shoulder rotator muscles
Trial: 18566882
Drug: LEGO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LEGO therapy
Trial: 8636309
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg finasteride daily for 3 months to 4 years (group 3)
Trial: 8636309
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg finasteride daily for 23-73 days (group 2)
Trial: 16649870
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia suggestion
Trial: 22409388
Drug: Vicodin (hydrocodone/acetaminophen)
RxNorm normalized name: acetaminophen / hydrocodone bitartrate Oral Tablet [Vicodin]
DrugBank: Hydrocodone (DB00956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vicodin (hydrocodone/acetaminophen)
Trial: 28271251
Drug: Gliclazide added
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide added to metformin/sitagliptin